[Antitumor effect of KRN 8602 for malignant brain tumors using collagen gel matrix assay].
Yuki
K
K
Dept. of Neurosurgery, Hiroshima Prefectural Hospital.
Tohru
U
U
Yasunori
K
K
Katsuzo
K
K
Kaoru
K
K
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001932:Brain Neoplasms / Q000473:pathology*; D002360:Carubicin / Q000031:analogs & derivatives* / Q000494:pharmacology; D003094:Collagen; D004354:Drug Screening Assays, Antitumor; D005782:Gels; D005909:Glioblastoma / Q000473:pathology; D006801:Humans; D008527:Medulloblastoma / Q000473:pathology; D051379:Mice; D009368:Neoplasm Transplantation; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D005782:Gels; C053537:morpholinoanthracycline MX2; D003094:Collagen; D002360:Carubicin